INTRODUCTION
There is an increasing awareness that vitamin D is more than just a fat-soluble vitamin that regulates calcium metabolism (1, 2) . More than 50 vitamin D metabolites have been identified with metabolic half-lives varying between hours and weeks. Plasma concentrations are predominantly influenced by recent sunlight exposure and dietary intake.
Quantification of 25-hydroxyvitamin D [25(OH)D]
, which has a plasma half-life of '3 wk, provides the most clinically useful assessment of an individual's vitamin D status. Deficiency based on the measurement of plasma 25(OH)D concentrations was recently shown to be associated with numerous chronic diseases, including cancer, diabetes, rheumatoid arthritis, cardiovascular disease, and mortality (2, 3) , and vitamin D apparently has antiinflammatory and antiproliferative properties (4) .
Some evidence indicates that, in patients with critical illness, 25(OH)D deficiency is associated with illness severity (4, 5) and it has been suggested that there is greater need for consideration of vitamin D deficiency and its supplementation in intensive care patients (4) .
It has become clear that only a very small proportion of 25(OH)D remains free or unbound in plasma (0.02-0.05%), with 80-90% circulating bound to vitamin D-binding protein (VDBP) and 10-20% bound to albumin. The plasma half-life of VDBP is also measured in days. However, plasma VDBP concentrations are recognized to decrease with cellular damage and tissue loss (6, 7) , and the molar ratio of 25(OH)D to VDBP has been suggested to provide a useful index of biological activity (8) .
Therefore, in view of the current debate regarding the threshold plasma concentration of 25(OH)D used to define vitamin D deficiency, factors that may confound its reliable assessment are of considerable importance. Good evidence indicates that plasma concentrations of other fat-soluble vitaminsincluding vitamin A (retinol), vitamin E (a-tocopherol), vitamin K (phylloquinone), and the carotenoids (lutein, lycopene, and a-and b-carotene)-decrease transiently after a significant and reproducible inflammatory insult (9) (10) (11) . These plasma measurements, therefore, may not be reliable indicators of the fat-soluble vitamin status where there is significant activation of the systemic inflammatory response (12) .
Louw et al (9) reported that plasma 25(OH)D concentrations decreased within 24 h of uncomplicated orthopedic surgery.
However, it was not clear whether this decrease was transient and whether the concentrations recovered. Also, other factors important in determining vitamin D concentration in plasma, such as VDBP, albumin, calcium, parathyroid hormone (PTH), and renal function, were not investigated. Therefore, the aim of the present study was to examine the relation between acute changes in the systemic inflammatory response and plasma concentrations of vitamin D after elective knee arthroplasty.
SUBJECTS AND METHODS

Patients and study design
All patients underwent primary knee replacement surgery because of osteoarthritis. Baseline demographic characteristicsincluding age, body mass index (BMI), and medical and drug history (including vitamin D and calcium supplementation)-were recorded. Surgical procedures, tourniquet times, anesthetic methods, perioperative intravenous fluid therapy, and packed red blood cell transfusions were recorded.
Venous blood samples were collected immediately before surgery and postoperatively beginning 6-12 h after surgery and each morning for the next 5 d; a final sample was collected 3 mo after surgery. Samples were collected between 0700 and 0800 after the patient had fasted from midnight the night before. Sample collection stopped if the patient was discharged before the fifth day.
Samples were centrifuged (500 · g, 4°C, 10 min), and plasma was removed carefully and stored at -70°C until analyzed. All samples from any given patient were assayed in a single batch for each of the analytes to minimize interbatch analytic variation. The study was approved by the local ethics committee. All subjects were informed of the purpose and procedures of the study, and all gave consent.
Analytic methods
Albumin, C-reactive protein (CRP), calcium, and creatinine were measured in accordance with the manufacturer's instructions, by routine laboratory procedures, with the use of an automated analyzer (Architect; Abbott Diagnostics, Abbott Park, Chicago, IL). For CRP, the limit of detection was 5 mg/L. The interassay CV was ,6% over the sample concentration range for the analytes measured.
Measurement of plasma 25(OH)D involved an automated solid-phase extraction (SPE) procedure, which was followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) (13). The lower limit of sensitivity was 4 nmol/L. Within-and between-assay precision was ,10% over the concentration range of 22.5 to 120 nmol/L. VDBP was measured by enzyme immunoassay with the use of a microtiter plate coated with polyclonal anti-VDBP antibody (Biosupply UK Ltd, Bradford, United Kingdom). The within assay precision was ,5%. Intact PTH was measured by using a chemiluminescent immunoassay (Liaison N-Tact PTH assay; Diasorin, Stillwater, MN). The within-assay CV of the method was ,10% over a concentration range of 0.8 to 5.0 nmol/L.
The estimated glomerular filtration rate (eGFR) was calculated by using the abbreviated MDRD 
Statistics
Data are presented as medians and ranges. Analysis of variance on all of the time period data were carried out by using Friedman's test. When appropriate, comparisons of data from different time periods were carried out by using Wilcoxon's signed-rank test. The Mann-Whitney U test was used to test for significance between 2 independent samples. Correlations were carried out by using Spearman's rank correlation (r s ). Because of the number of statistical comparisons, a P value ,0.01 was considered to be significant. SPSS software (SPSS Inc, Chicago, IL) was used for the analysis.
RESULTS
Thirty-three patients (14 men, 19 women) aged 52-81 y (median age: 72 y) who underwent elective primary knee arthroplasty for osteoarthritis and who had no evidence of a systemic inflammatory response (CRP 10 mg/L) were entered into the study. Preoperatively, albumin and adjusted calcium concentrations were within the reference intervals. None of the subjects had evidence of renal failure (eGFR . 60 mL Á min 21 Á 1.73 m 22 ). Most of the patients had secondary hyperparathyroidism (elevated PTH .5 pmol/L) and baseline plasma 25(OH)D concentrations that were considered to be in the deficient range (,50 nmol/L; 16).
All patients received intravenous fluids intraoperatively and in the immediate postoperative period to maintain hydration and intravenous access if required for clinical care. The median volume of intravenous fluid administered in the first 6 h was 1500 (range: 650-3000) mL, and 550 (150-1150) mL was administered between 6 and 12 h. An additional 500 (0-1500) mL was administered by the following morning. Only 7 patients received further intravenous fluids between the first and second postoperative days. Thereafter, all intravenous fluid therapy was discontinued, except in one patient, who received 1000 mL on the third postoperative day.
Eight patients received a blood transfusion consisting of between 1 and 2 units of packed red blood cells during the study period. No packed red blood cell transfusions were administered within the first 24 h; 3 patients received a transfusion between samples on the first and second postoperative days. An additional 3 patients received blood before the third postoperative day sample, and 2 more patients received blood before the final sample.
Plasma 25(OH)D concentrations according to baseline characteristics of the patients who underwent elective surgery for knee arthroplasty are shown in Table 1 . Age, sex, BMI, season, medical history, and medication use were not associated with significant differences in preoperative plasma 25(OH)D concentrations.
Analysis of serial postoperative values over the study 5-d period ( Table 2) showed a large increase in circulating CRP concentrations by day 2 (P , 0.001), and the concentration had not returned to preoperative concentrations by the 5th postoperative day (P , 0.001). The eGFR did not change during the postoperative period. The adjusted plasma calcium concentration decreased significantly within 2 d (both P , 0.01), and a trend toward recovery to preoperative values was observed. PTH concentrations did not change significantly over the 5-d study period. A significant decrease in 25(OH)D of '40% (P , 0.001) was observed by 6-12 h, and 25(OH)D had not returned to preoperative concentrations by day 5 (P , 0.001). The 25(OH)D binding proteins (VDBP and albumin) decreased significantly, by '15%, by day 1 (both P , 0.001). Although VDBP concentrations recovered to preoperative values within the 5-d postoperative study period, albumin concentrations did not. The molar ratio and the calculated free 25(OH)D concentration decreased significantly by '40% within 24 h and did not recover to preoperative values (P , 0.001).
The preoperative and 3-mo values are shown in Table 3 . In the current study, such elective surgery presents the opportunity to examine how lipid-soluble vitamin concentrations are altered in the inflammatory state without the potential confounding of the disease state. It was of interest that the magnitude of the decrease in 25(OH)D, the molar ratio of 25(OH)D to One interpretation of these results would be that the present study was underpowered to detect such differences. Nevertheless, on the basis of the results of the current study, it is clear that the influence of the postoperative metabolic response is of a larger magnitude. Moreover, the current results are consistent with previous studies of the effect of the systemic inflammatory response on fat-soluble vitamins (9-11). One possible explanation of such a large decrease in plasma 25(OH)D concentrations ('40%) in the immediate postoperative period may be that there was a loss of VDBPs, and therefore of vitamin D, from the plasma as part of the redistribution that occurs as part of the acute phase response. However, the reduction in VDBP and albumin was considerably smaller ('20%) such that the molar ratios were lower in the perioperative period. Furthermore, the free 25(OH)D concentration, widely regarded as the physiologically important form, was similarly lower in the immediate postoperative and followup periods, and minor changes in adjusted plasma calcium and no significant changes in PTH concentrations (sensitive to changes in calcium status) were observed.
Another possible explanation for the current results is that the turnover and cellular uptake of 25(OH)D may have increased. Although it would appear unlikely that turnover could explain the rapid decrease, given that the biological half-life of vitamin D stores is '3 wk (17), some evidence indicates that vitamin D can be actively taken up by inflammatory cells, particularly macrophages (18) .
Finally, a dilutional effect of postoperative fluids might be considered a plausible explanation. Krishnan et al (19) recently reported that acute changes in fluid balance are associated with acute reductions in plasma 25(OH)D concentrations. They therefore urged caution when interpreting serum vitamin D concentrations in the context of major resuscitation in critically ill patients, which may be relevant to the results of the current study. However, in the study by Krishnan et al, patients underwent immediate hemodilution from cardiopulmonary bypass. In contrast, in the current study, patients underwent routine administration of lower volumes of isotonic fluid over several hours. This fluid is administered to maintain fluid balance rather than to expand fluid volumes. The administration of such a fluid It was of interest that plasma 25(OH)D concentrations remained low at 3 mo. The reasons for this are not clear. However, CRP concentrations had normalized at 3 mo. Therefore, the persistent low plasma 25(OH)D concentrations at 3 mo may reflect the rehabilitation process after surgery and the fact that patients were not exposed to sunlight. Indeed, analysis of seasonality at 3 mo showed no significant association between season and plasma 25(OH)D concentrations.
In the literature, there is currently no consensus concerning what a normal range should be for plasma 25(OH)D. The Institute of Medicine Dietary Reference Intakes for calcium and vitamin D (2010), states that 'there may be reasons for concern at serum 25(OH)D concentrations above 50 ng/mL (125 nmol/L)." The report also acknowledges the lack of evidence-based consensus as problematic and of concern because "individuals with serum 25(OH)D levels above 50 nmol/L (20 ng/mL) may at times be classified as deficient." Therefore, in the current study, we consider it reasonable to use the existing threshold of ,50 nmol/L (20) . Furthermore, this threshold has, in particular, been shown to be associated with increases in PTH (21, 22) .
The current approaches to address the problem of interpreting low circulating 25(OH)D concentrations would be either to correct concentrations for changes in the binding protein or to calculate or measure the free (physiologically active) form. However, in the current study, correction for the VDBP or the calculation of the free form was not useful because 25(OH)D concentrations decreased further than the corresponding VDBP and albumin. A more radical alternative approach would be to measure directly intracellular vitamin concentrations. We recently validated the analysis of red blood cells for vitamin B-6, vitamin E, and riboflavin concentrations in subjects undergoing an elective knee arthroplasty with a consequent acute systemic inflammatory response (10, 23) and in patients with critical illness (12, 24, 25) . Whereas plasma concentrations of these vitamins deceased rapidly on activation of the systemic inflammatory response, red blood cell concentrations remained stable. Therefore, it would be of considerable interest to examine intracellular vitamin D concentrations for, example, white blood cells.
Irrespective of these explanations and alternative measurements, the current results add further evidence to the concept that plasma concentrations of fat-soluble vitamins (now including vitamin D) are unlikely to reliably reflect vitamin status in the presence of a systemic inflammatory response (12, (24) (25) (26) (27) (28) . However, changes in CRP in chronic inflammatory conditions are likely to be of a lesser magnitude than those seen after knee arthroplasty in the current study. Therefore, it would not be reasonable to extrapolate the data from the present study to the relation between the systemic inflammatory response and plasma 25(OH)D concentrations in chronic disease. Nonetheless, the current results suggest that plasma 25(OH)D concentrations might be lower in the presence of a lower-grade systemic inflammatory response. Clearly, additional studies of chronic inflammatory disease are required to test this hypothesis.
In summary, the results of the current study indicate that plasma concentrations of 25(OH)D decrease after an inflammatory insult, and this decrease appears to persist for several months. Moreover, this conclusion was not altered when plasma values were corrected for binding proteins and were not reflected in either adjusted calcium or PTH concentrations. Therefore, plasma concentrations of 25(OH)D in the presence of a systemic inflammatory response are unlikely to be a reliable measure of vitamin D status.
